3E Bioventures

RNA Concept 3D Render
Biotech

RNA biotech emerges with $52M and clinical rare disease asset

Arnatar currently touts seven assets, with six preclinical programs that range across cardiometabolic, inflammatory and CNS conditions.
Gabrielle Masson Aug 25, 2025 10:13am
blue illustration of neurons

Regenacy Pharma snags $30M for diabetic neuropathy treatment

Mar 25, 2020 11:15pm